Overview

Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to demonstrate the bioequivalence (BE) of alprazolam 1 mg tablet with Xanax® 1 mg tablet under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Alprazolam